LNB
HQL

Ledyard National Bank’s abrdn Life Sciences Investors HQL Stock Holding History

Ledyard National Bank’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-3,986
Closed -$60K – 423
2018
Q4 		$60K Hold
3,986
– – 0.01% 384
2018
Q3 		$81K Buy
3,986
+81
+2% +$1.61K 0.01% 373
2018
Q2 		$73K Buy
3,905
+80
+2% +$1.5K 0.01% 387
2018
Q1 		$74K Buy
+3,825
New +$76.6K 0.01% 394

Other funds holding HQL

NIM
Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.27B AUM 18.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 24.86% 1-Year Est. Return

Ledyard National Bank's HQL Position: Q1 2019 in Review

Ledyard National Bank sold out of abrdn Life Sciences Investors (HQL) in Q1 2019, closing a stake of 3,986 shares — an estimated $60K sold.

Ledyard National Bank first reported a position in HQL in Q1 2018 and held it in 4 quarters. The position peaked at $81K in Q3 2018. 56 funds tracked by Wall St. Rank hold HQL as of Q1 2019.

  • Ledyard National Bank reported no remaining abrdn Life Sciences Investors position as of Q1 2019 after selling out during the quarter.
  • Ledyard National Bank sold 3,986 abrdn Life Sciences Investors shares in Q1 2019, an estimated $60K.
  • Ledyard National Bank first reported a position in abrdn Life Sciences Investors in Q1 2018 and held it in 4 quarters.
  • Ledyard National Bank's abrdn Life Sciences Investors position peaked at $81K in Q3 2018.
  • 56 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q1 2019.

Based on Ledyard National Bank's 13F filing for Q1 2019, filed 12 Apr 2019.